Johnson & Johnson announced its second quarter 2026 financial results on July 15, 2026, for the quarter ended June 28, 2026. The results were disclosed in a press release attached to this 8-K filing.
View Full Filing (SEC EDGAR)Johnson & Johnson
+$68.4B
Net Activity
Data as of: 2026-03-31
Institutions Holding
6182
Popularity Rank
#1
Avg Weight
0.68%
Total Value
$513.2B

6182 institutions currently hold JNJ, with 2689 net buyers and 2946 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
2946
Net Buying Institutions
2689
Top 5 by Value
Across its top 20 institutional holders, JNJ's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 5/100, avg. turnover score 17/100).
+$241.1B
Total Buy Value
$198.9B
Total Sell Value
2689
Net Buyers
2946
Net Sellers
JNJ does not currently show a 13F-and-insider convergence signal — its insider confidence score is 0/100, below the threshold this product uses to flag combined buying pressure.
13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.
Terms of Use for AI
AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/JNJ
0
unique buyers
—
buy value
12-Month Buy/Sell Activity
| Action | Insider | Date | Value |
|---|---|---|---|
| Sell | Vanessa Broadhurst | 2026-07-20 | $5.79M |
| Sell | Decker Robert J | 2026-02-27 | $1.01M |
| Sell | Schmid Timothy | 2026-02-20 | $325K |
| Sell | Schmid Timothy | 2026-02-18 | $2.20M |
| Sell | Schmid Timothy | 2026-02-18 | $3.33M |
| Sell | Swanson James D. | 2026-02-17 | $4.98M |
| Sell | Wolk Joseph J | 2026-02-17 | $4.68M |
| Sell | Wolk Joseph J | 2026-02-17 | $6.06M |
2
Filings (90d)
$8.19M
Total Est. Value
33K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Broadhurst Vanessa | 2026-07-20 | $5.79M |
| Wengel Kathryn E | 2026-06-11 | $2.40M |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Johnson & Johnson announced its second quarter 2026 financial results on July 15, 2026, for the quarter ended June 28, 2026. The results were disclosed in a press release attached to this 8-K filing.
View Full Filing (SEC EDGAR)478160104, 00BY7QL61, 47816010 , 478160904, 478160954, 478366107, G51502105, G51502905, g51502105
Other stocks in the same GICS sector
Institutions Holding
4,338
Total reported value
$730.5B
3675 institutions currently hold both JNJ and this stock
Institutions Holding
4,025
Total reported value
$283.9B
3598 institutions currently hold both JNJ and this stock
Institutions Holding
3,721
Total reported value
$236.1B
3416 institutions currently hold both JNJ and this stock
The most-added stocks by 13F institutions this quarter
Institutions Holding
6,151
Total reported value
$2.1T
3246 13F institutions increased their position this quarter
Institutions Holding
5,958
Total reported value
$1.5T
3029 13F institutions increased their position this quarter
Institutions Holding
5,766
Total reported value
$3.0T
2744 13F institutions increased their position this quarter
Access JNJ's institutional ownership data programmatically:
REST API
curl https://alphasmo.com/api/v1/market/stock/JNJCLI
npx alphasmo stocks get JNJFull API & MCP documentation →